within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10A_InsulinsAndAnalogues.A10AC01_InsulinHuman;

model InsulinHuman
  extends Pharmacolibrary.Drugs.ATC.A.A10AC01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A10AC01</td></tr><td>route:</td><td>subcutaneous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Insulin (human) is a peptide hormone used for the treatment of diabetes mellitus to control blood glucose levels. It is a replacement for endogenous insulin in patients with type 1 diabetes and is also used in type 2 diabetes when oral therapies are inadequate. It is approved for use worldwide and administered via subcutaneous, intravenous, or intramuscular routes.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers (males and females), with subcutaneous administration of regular human insulin.</p><h4>References</h4><ol><li><p>Nishimura, E, et al., &amp; Haahr, H (2021). Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing. <i>BMJ open diabetes research &amp; care</i> 9(1) –. DOI:<a href=&quot;https://doi.org/10.1136/bmjdrc-2021-002301&quot;>10.1136/bmjdrc-2021-002301</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34413118/&quot;>https://pubmed.ncbi.nlm.nih.gov/34413118</a></p></li><li><p>Ma, X, et al., &amp; Leishman, D (2022). Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin Administered via Continuous Subcutaneous Insulin Infusion Versus Subcutaneous Injection in Adults With Type 2 Diabetes and High-Dose Insulin Requirements. <i>Journal of diabetes science and technology</i> 16(2) 401–407. DOI:<a href=&quot;https://doi.org/10.1177/1932296820972719&quot;>10.1177/1932296820972719</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33242998/&quot;>https://pubmed.ncbi.nlm.nih.gov/33242998</a></p></li><li><p>Brogden, RN, &amp; Heel, RC (1987). Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use. <i>Drugs</i> 34(3) 350–371. DOI:<a href=&quot;https://doi.org/10.2165/00003495-198734030-00003&quot;>10.2165/00003495-198734030-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3315622/&quot;>https://pubmed.ncbi.nlm.nih.gov/3315622</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end InsulinHuman;
